v3.24.2.u1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (4,333,949) $ (1,919,908)
Adjustments to reconcile net loss to net cash used in operating activities    
Amortization of debt discount 605,630 49,122
Issuance cost from shares issued on extension of bridge loan 126,000
Stock-based compensation 751,530 599,559
Changes in operating assets and liabilities:    
Accounts payable and accrued expenses (1,481,113) 548,297
Accrued compensation (282,518) 229,941
Due from Chromocell Corporation (45,786)
Prepaid expenses (158,102)
Net Cash Used In Operating Activities (4,944,308) (366,989)
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from loan payable, net of debt discount 1,455,416 90,157
Proceeds from loan payable - related party, net of debt discount 131,868 303,651
Payment of bridge loan, net of debt discount (214,757)
Common stock issued for cash 5,972,000
Recission of common stock (91,512)
Net Cash Provided By Financing Activities 7,253,015 393,808
NET INCREASE IN CASH 2,308,707 26,819
CASH AT BEGINNING OF PERIOD 96,391 55,074
CASH AT END OF PERIOD 2,405,098 81,893
Supplemental cash flow information:    
Cash paid for income taxes
Cash paid for interest expense
NONCASH INVESTING AND FINANCING ACTIVITIES:    
Debt discount from common stock issued for extension of bridge loan 447,779 126,000
Conversion of notes 1,362,821
Transfer of liabilities to Chromocell Corp for Preferred Stock $ 2,153,362

Source